Cite

HARVARD Citation

    Shaw, T. et al. (n.d.). P220 Long-term safety profile of upadacitinib in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Rheumatology. p. . [Online]. 
  
Back to record